MorphoSys To Take Charge Of EUR 231 Mln After Consolidation

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR) said Thursday that it will account for a non-cash impairment charge on goodwill in the amount of about 231 million euros. The write-down results from

Related Keywords

Martinsried , Bayern , Germany , , Constellation Pharmaceuticals Inc , Constellation Pharmaceuticals , Morphosys , Lake , Charge , After , Consolidation , Research , Discovery , Functions ,